The clinical course of recurrent respiratory papillomatosis after the use of cidofovir is influenced by multiple factors

Eur Arch Otorhinolaryngol. 2015 Jul;272(7):1819-20. doi: 10.1007/s00405-014-3366-y. Epub 2014 Oct 29.

Authors

Michel R M San Giorgi¹, Robin E A Tjon Pian Gi, Frederik G Dikkers

Affiliation

¹ Department of Otorhinolaryngology, Head and Neck Surgery, University of Groningen, University Medical Center Groningen, P.O. Box 30.001, 9700 RB, Groningen, The Netherlands, m.r.m.san.giorgi@umcg.nl.

PMID: 25351501
DOI: 10.1007/s00405-014-3366-y

No abstract available

Publication types

Letter
Comment

MeSH terms

Cytosine / analogs & derivatives*
Female
Humans
Male
Organophosphonates / administration & dosage*
Papillomaviridae*
Papillomavirus Infections / drug therapy*
Respiratory Tract Infections / drug therapy*

Substances

Organophosphonates
Cytosine